Blockchain Registration Transaction Record

Clinilabs Strengthens Leadership Team to Drive CNS Innovation

Clinilabs enhances its leadership with David Hagerman as CFO and Jeanine Falinski as SVP of Commercial Development, aiming to advance CNS drug and tech development.

Clinilabs Strengthens Leadership Team to Drive CNS Innovation

The strategic appointments at Clinilabs signal a robust phase of growth and innovation in CNS drug and technology development. For stakeholders in the healthcare and pharmaceutical industries, this move underscores the increasing importance of specialized expertise in addressing complex CNS disorders. Patients and healthcare providers stand to benefit from accelerated development and approval of new therapies, potentially improving outcomes for those affected by psychiatric, neurological, and substance use disorders.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x5b8ca9d2efab9b65b23f40de1de503b06b3e927a2a72bc8cf8bab66ed883effc
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintpaleMWJg-4f50040ea67c6231bd90cee85951dfdf